KYNBNasdaq United States
Market cap
$29.430 M
$7.27 +4.15%
Close of 7 Aug 2026
Revenue
$6.44M
#3257 by revenue
Earnings
$183.5M
#1048 by earnings
Shares outstanding
4,048,112
Latest filing cover page
P/E ratio
0.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Kyntra Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.